Skip to main content
. 2016 May;39(3):272–280. doi: 10.1080/10790268.2015.1114224

Table 3.

The ASIA classification at 6 days, 3 and 6 months in 64 patients with traumatic spinal cord injury who received progesterone and vitamin D (n = 32) or placebo (n = 32)

Progesterone + Vitamin D (n = 32) Placebo (n = 32) P-value
ASIA class at 3 days
A (%) 0 (0.0%) 0 (0.0%) 0.395
B (%) 11 (34.4%) 13 (40.6%)
C (%) 10 (31.2%) 6 (18.8%)
D (%) 9 (28.1%) 10 (31.2%)
E (%) 2 (6.3%) 3 (9.4%)
ASIA class at 6 days
A (%) 0 (0.0%) 0 (0.0%) 0.774
B (%) 12 (37.4%) 10 (31.3%)
C (%) 11 (34.4%) 9 (28.1%)
D (%) 7 (21.9%) 10 (31.2%)
E (%) 2 (6.3%) 3 (9.4%)
ASIA class at 3 months
A (%) 0 (0.0%) 0 (0.0%) 0.903
B (%) 10 (31.2%) 10 (31.2%)
C (%) 7 (21.9%) 6 (18.8%)
D (%) 9 (28.1%) 11 (34.4%)
E (%) 6 (18.8%) 5 (15.6%)
ASIA class at 6 months
A (%) 0 (0.0%) 0 (0.0%) 0.664
B (%) 6 (18.8%) 7 (21.9%)
C (%) 8 (24.9%) 9 (28.1%)
D (%) 6 (18.8%) 6 (18.8%)
E (%) 12 (37.5%) 10 (31.2%)